Phocaeicola vulgatus: The Carbohydrate Degrader in Your Gut

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

This test measures Phocaeicola vulgatus levels in your gut microbiome to identify microbial imbalances. Abnormal levels are associated with gut inflammation and inflammatory bowel–type conditions, so detecting them can help guide interventions to reduce risk of chronic digestive symptoms.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Quantifying a workhorse carbohydrate degrader

The Phocaeicola vulgatus test quantifies this single species within the ecosystem of your gut. P. vulgatus is a common resident of healthy adult guts and specializes in breaking down complex carbohydrates, helping generate metabolites like acetate and propionate that influence gut pH, motility, and cross‑feeding of other microbes. Like many “core” commensals, its impact is context dependent: levels that are too high or too low may appear in different clinical scenarios. The test translates that complexity into a concrete, trackable measurement you and your clinician can interpret alongside symptoms and other biomarker data.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

A concrete read on a common resident

Your gut microbes interact with you every time you eat, train, or travel. Testing helps convert that invisible activity into patterns you can understand. P. vulgatus is a workhorse degrader of dietary fibers and plant polysaccharides, which supports downstream production of short‑chain fatty acids that nourish the intestinal lining and help regulate immune tone. Shifts in this species can appear with low‑fiber eating, ultra‑processed foods, restrictive dieting, or after a course of antibiotics. Research cohorts have also reported higher relative abundance of P. vulgatus in some people with irritable bowel patterns or inflammatory bowel conditions, and in certain metabolic phenotypes—though findings vary by population, methods, and coexisting species, and more research is needed. That’s why measuring this organism within your own microbiome, rather than relying on generic rules, is valuable.

Zooming out, microbiome testing connects the dots between everyday choices and long‑term outcomes. It can clarify how increased fermentable fiber, time‑restricted eating patterns, or GLP‑1 medications influence microbial balance, stool regularity, and inflammation signals over weeks to months. The practical goal isn’t to “chase” a single species but to learn whether your microbiome is trending toward resilience: diverse, stable, and rich in beneficial functions. A Phocaeicola vulgatus test becomes one reference point in that bigger picture—particularly useful when symptoms persist, after significant lifestyle shifts, or when you and your clinician are personalizing nutrition for digestion, energy, or workout recovery.

Test 100+ biomarkers

One blood draw. A full picture of your health, explained in plain language.

Book your test

What a relative-abundance report reveals

Results are typically reported as the relative abundance of P. vulgatus compared with a reference population, and sometimes as an absolute count. In general, well‑balanced microbiomes show higher overall diversity with beneficial genera like Bifidobacterium and Faecalibacterium present; P. vulgatus is commonly detected at modest levels within that mix. Because genetics, geography, and diet all shape the microbiome, “normal” ranges vary widely.

When P. vulgatus sits in a moderate band, it often signals robust carbohydrate breakdown, cooperative cross‑feeding with butyrate producers, and steady short‑chain fatty acid production. That pattern aligns with efficient digestion, a calmer immune tone, and a sturdier gut barrier.

If P. vulgatus is disproportionately high relative to diversity, it may accompany lower butyrate‑producing species or higher lipopolysaccharide pathway signals—patterns linked in studies to bloating, loose stools, or low‑grade inflammation. If unusually low, it may reflect recent antibiotics, very low fiber intake, or reduced capacity to harvest energy from complex carbs. These are prompts for exploration rather than diagnoses.

Data that add context

Interpret your result alongside symptoms and other labs (for example, fecal calprotectin for inflammation, stool short‑chain fatty acids or bile acids, and systemic markers like CRP, triglycerides, or HbA1c). Remember practical limits: stool represents a snapshot; day‑to‑day variation is real; 16S profiling may miss strain‑level nuances that shotgun metagenomics can detect; and qPCR provides absolute counts but for targeted organisms only. Method differences and sample handling can shift numbers, so trends over time are often most informative.

Frequently Asked Questions

References

  1. Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, Forslund K, Hildebrand F, Prifti E, Falony G, Le Chatelier E, Levenez F, Doré J, Mattila I, Plichta DR, Pöhö P, Hellgren LI, Arumugam M, Sunagawa S, ... Pedersen O (2016). Human gut microbes impact host serum metabolome and insulin sensitivity. *Nature*, *535*(7612), 376-381. https://doi.org/10.1038/nature18646
  2. Keitel L, Schick B, Pohen G, Yordanov S, Büchs J (2025). Online monitored characterization of *Phocaeicola vulgatus* for organic acid production using anaerobic microtiter plate cultivations. *Biotechnology Progress*, *41*(2), e3526. https://doi.org/10.1002/btpr.3526
  3. Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, Lener E, Mele MC, Gasbarrini A, Collado MC, Cammarota G, Ianiro G (2023). Short-chain fatty-acid-producing bacteria: Key components of the human gut microbiota. *Nutrients*, *15*(9), 2211. https://doi.org/10.3390/nu15092211
  4. Jovel J, Patterson J, Wang W, Hotte N, O'Keefe S, Mitchel T, Perry T, Kao D, Mason AL, Madsen KL, Wong, G. K.-S. (2016). Characterization of the gut microbiome using 16S or shotgun metagenomics. *Frontiers in Microbiology*, *7*, 459. https://doi.org/10.3389/fmicb.2016.00459
  5. Drago L (2025). Navigating microbiome variability: Implications for research, diagnostics, and direct-to-consumer testing. *Frontiers in Microbiology*, *16*, 1580531. https://doi.org/10.3389/fmicb.2025.1580531

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize100+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions from a single blood draw - then act on what you find.

$199

/year*

100+ biomarkers from a single blood draw

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.55 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 100+ biomarkers from a single blood draw each year. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.